申联生物 (688098.SH)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

利润表(单季度)(申联生物)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2023年第三季度2023年第二季度2023年第一季度2022年第四季度2022年第三季度2022年第二季度2022年第一季度
上市前/上市后 上市后上市后上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 116,354,484.5441,219,696.8181,851,831.1842,009,557.09148,322,330.4749,213,107.6189,049,518.25
 营业收入(元) 116,354,484.5441,219,696.8181,851,831.1842,009,557.09148,322,330.4749,213,107.6189,049,518.25
二、营业总成本(元) 82,540,975.5152,042,394.2663,992,804.5750,777,637.8987,883,683.3948,997,048.5163,940,663.47
 营业成本(元) 30,612,107.3413,633,474.0222,544,394.3711,544,517.8633,824,627.4312,530,041.7423,496,430.29
 研发费用(元) 11,380,013.7810,121,905.608,757,354.7712,645,781.9710,251,744.3710,944,658.715,196,621.48
 营业税金及附加(元) 1,150,507.761,204,172.78988,911.58949,360.78960,159.72590,256.61929,922.82
 销售费用(元) 26,217,998.9515,939,897.3918,420,235.0219,827,268.1019,100,225.2312,939,166.0321,249,662.03
 管理费用(元) 13,546,856.0611,326,091.6213,441,506.906,012,669.5524,028,080.8712,276,245.3913,254,484.04
 财务费用(元) -366,508.38-183,147.15-159,598.07-201,960.37-281,154.23-283,319.97-186,457.19
  其中:利息收入(元) 377,971.84219,586.06160,635.85197,621.48318,142.58318,750.95189,752.69
 资产减值损失(元) -6,731.62-725.4211,379.8926,108.38-11,851.03-3,962.941,417.59
 信用减值损失(元) -3,540,656.13-1,200,551.95-1,523,710.84-510,028.38-3,432,971.39-3,854,065.09-715,881.80
三、其他经营收益
 加:公允价值变动收益(元) 756,224.04-2,443,245.34766,200.29-51,441.04-635,500.98-345,815.551,377,988.77
 加:投资收益(元) 740,922.955,524,757.131,702,512.35-3,708,255.131,440,069.962,741,018.912,493,199.60
  其中:对联营企业和合营企业的投资收益(元) -4,804.588,233.59-20.66-4,708.035,559.431,352.243,391.09
 资产处置收益(元) ----196,771.54---
 其他收益(元) 268,958.78942,958.78346,929.93656,834.781,819,958.78403,070.06412,855.24
四、营业利润(元) 32,032,227.05-7,999,504.2519,162,338.23-12,551,633.7359,951,407.17-843,695.5128,678,434.18
 加:营业外收入(元) 12,899.74744,927.000.100.01---
 减:营业外支出(元) 350,357.60185,055.8151,029.82186,767.31217,200.00280,000.0048,500.00
五、利润总额(元) 31,694,769.19-7,439,633.0619,111,308.51-12,738,401.0359,783,145.61-1,123,695.5128,629,934.18
 减:所得税费用(元) 5,142,533.51-1,504,170.453,243,675.91-1,358,004.3810,706,942.13-474,155.134,705,057.49
六、净利润(元) 26,552,235.68-5,935,462.6115,867,632.60-11,380,396.6549,076,203.48-649,540.3823,924,876.69
(一)按经营持续性分类
  持续经营净利润(元) 26,552,235.68-5,935,462.6115,867,632.60-11,380,396.6549,076,203.48-649,540.3823,924,876.69
(二)按所有权归属分类
  归属于母公司股东的净利润(元) 27,192,127.78-5,935,462.6115,867,632.60-11,266,341.6349,080,448.93-644,472.8923,928,559.11
  少数股东损益(元) ----114,055.02-4,245.45-5,067.49-3,682.42
 扣除非经常性损益后的净利润(元) 26,002,876.50-9,825,154.5613,517,692.00-13,491,733.9746,714,251.64-2,783,855.9020,331,229.47
七、每股收益
 一、基本每股收益(元) 0.07-0.020.04-0.030.12-0.06
 二、稀释每股收益(元) 0.07-0.020.04-0.030.120.010.05
九、综合收益总额(元) 26,552,235.68-5,935,462.6115,867,632.60-11,380,396.6549,076,203.48-649,540.3823,924,876.69
 归属于母公司所有者的综合收益总额(元) 27,192,127.78-5,935,462.6115,867,632.60-11,266,341.6349,080,448.93-644,472.8923,928,559.11
 归属于少数股东的综合收益总额(元) ----114,055.02-4,245.45-5,067.49-3,682.42
公告日期 2023-10-312023-08-302023-04-272023-04-272022-10-262022-08-302022-04-28
审计意见(境内) 标准无保留意见

前瞻产业研究院